<!DOCTYPE html>
<html lang="ko">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Our Research - Min-Guk Cho: Research Hub</title>
    <style>
        /* 모든 페이지에 공통으로 적용되는 스타일 */
        :root {
            --primary-color: #005A9C; --secondary-color: #007acc; --dark-color: #2c3e50; 
            --light-color: #f8f9fa; --white-color: #fff; --text-color: #333; --border-color: #dee2e6;
        }
        html { scroll-behavior: smooth; }
        body { font-family: 'Segoe UI', 'Helvetica Neue', Arial, sans-serif; line-height: 1.8; margin: 0; padding: 0; background-color: var(--light-color); color: var(--text-color); }
        .container { width: 90%; max-width: 1100px; margin: auto; overflow: hidden; }
        #main-nav { background: rgba(44, 62, 80, 0.95); backdrop-filter: blur(10px); position: sticky; top: 0; z-index: 1000; padding: 15px 0; box-shadow: 0 2px 10px rgba(0,0,0,0.1); }
        #main-nav .container { display: flex; justify-content: space-between; align-items: center; }
        #main-nav .logo { font-size: 1.6em; font-weight: 600; color: var(--white-color); text-decoration: none; }
        #main-nav ul { padding: 0; margin: 0; list-style: none; display: flex; }
        #main-nav ul li a { color: var(--white-color); text-decoration: none; padding: 8px 16px; font-weight: 500; transition: background-color 0.3s, color 0.3s; border-radius: 5px; }
        #main-nav ul li a:hover, #main-nav ul li a.active { background-color: var(--primary-color); }
        .content-section { padding: 60px 20px; background: var(--white-color); margin: 30px 0; border-radius: 12px; box-shadow: 0 4px 20px rgba(0,0,0,0.05); }
        .content-section h2 { text-align: center; margin-top: 0; margin-bottom: 50px; font-size: 2.5em; font-weight: 600; color: var(--dark-color); position: relative; padding-bottom: 15px; }
        .content-section h2::after { content: ''; position: absolute; bottom: 0; left: 50%; transform: translateX(-50%); width: 80px; height: 4px; background-color: var(--primary-color); border-radius: 2px; }
        footer { text-align: center; padding: 40px; margin-top: 30px; background: var(--dark-color); color: var(--grey-color); }
        .visitor-counter { margin-top: 20px; }
        @media(max-width: 768px) {
            #main-nav .container { flex-direction: column; }
            #main-nav ul { margin-top: 15px; flex-wrap: wrap; justify-content: center; }
        }
    </style>
</head>
<body>
    <nav id="main-nav">
        <div class="container">
            <a href="index.html" class="logo">Cho' Hub</a>
            <ul>
                <li><a href="team.html">Our Team</a></li>
                <li><a href="research.html">Research</a></li>
                <li><a href="publications.html">Publications</a></li>
                <li><a href="photos.html">Photos</a></li>
                <li><a href="contact.html">Contact</a></li>
            </ul>
        </div>
    </nav>
    <div class="container">
        <div id="research" class="content-section">
            <h2>Our Research</h2>
            <p>
                Our research investigates the dynamic interplay between DNA damage repair, innate immune signaling, and genomic instability to uncover novel therapeutic targets for cancer treatment. A key focus is the role of the Mre11 gene in triple-negative breast cancer, where we discovered that MRE11 regulates innate immune signaling and necroptosis through the cGAS-STING-ZBP1 pathway, contributing to tumor suppression. This finding, published in Nature, highlights how DNA damage responses can drive immune activation, paving the way for innovative cancer therapies.
            </p>
            <p>
                We are currently exploring mechanisms to amplify innate immune responses triggered by DNA damage and genomic instability, with a particular emphasis on the cGAS-STING pathway. Our work aims to identify novel regulatory mechanisms within this pathway and systematically map the detailed activation processes of cGAS induced by DNA damage. Using advanced approaches such as CRISPR-based gene editing, high-throughput sequencing, and immune profiling, we seek to discover new molecular targets to enhance the efficacy of cancer treatments. Our long-term goal is to develop transformative therapeutic strategies by leveraging these insights at the intersection of cancer biology and immunology.
            </p>
            <p>
                <strong>Research Interests:</strong> DNA Damage Repair, Innate Immunity, Genomic Instability, Cancer Biology, Immunology, Cell Cycle Regulation
            </p>      
        </div>
    </div>
    <footer>
        <p>&copy; 2025 Min-Guk Cho. All Rights Reserved.</p>
        <div class="visitor-counter">
            <a href="https://hits.seeyoufarm.com"><img src="https://hits.seeyoufarm.com/api/count/incr/badge.svg?url=https%3A%2F%2Fbroselack.github.io&count_bg=%23005A9C&title_bg=%232C3E50&icon=&icon_color=%23E7E7E7&title=HITS&edge_flat=false"/></a>
        </div>
    </footer>
    <script>
        document.addEventListener('DOMContentLoaded', function() {
            const links = document.querySelectorAll('#main-nav ul li a');
            const currentPage = 'research.html';
            links.forEach(link => {
                if (link.getAttribute('href') === currentPage) {
                    link.classList.add('active');
                }
            });
        });
    </script>
</body>
</html>
